Found: 70
Select item for more details and to access through your institution.
The efficacy and safety of anamorelin among patients with diabetes.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1115, doi. 10.1007/s10147-024-02546-8
- By:
- Publication type:
- Article
Suitability of frozen cell pellets from cytology specimens for the Amoy 9‐in‐1 assay in patients with non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 21, p. 1665, doi. 10.1111/1759-7714.15382
- By:
- Publication type:
- Article
Efficacy of second-line chemotherapy in patients with pulmonary large cell neuroendocrine carcinoma.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-58327-w
- By:
- Publication type:
- Article
Relationship between patterns of immunohistochemical conventional neuroendocrine markers and efficacy of immune check point inhibitors in patients with extensive disease small cell lung cancer.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 6, p. 477, doi. 10.1111/1759-7714.15218
- By:
- Publication type:
- Article
Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 2, p. 96, doi. 10.1007/s10147-023-02451-6
- By:
- Publication type:
- Article
Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second‐line chemotherapy in patients with small cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 35, p. 3475, doi. 10.1111/1759-7714.15140
- By:
- Publication type:
- Article
Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: treatment rationale and protocol design of the B-DASH study (WJOG 14720 L)
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11417-w
- By:
- Publication type:
- Article
Immunohistochemical analysis of B7-H3 expression in patients with lung cancer following various anti-cancer treatments.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 2, p. 356, doi. 10.1007/s10637-023-01353-8
- By:
- Publication type:
- Article
Validation of the initial brain metastasis velocity in non-small cell lung cancer at a single cancer center.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 162, n. 2, p. 435, doi. 10.1007/s11060-023-04300-y
- By:
- Publication type:
- Article
Efficacy and safety of carboplatin and etoposide in older extensive‐stage small‐cell lung cancer patients with a poor performance status.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 9, p. 805, doi. 10.1111/1759-7714.14811
- By:
- Publication type:
- Article
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-30676-y
- By:
- Publication type:
- Article
Clinical impact of tumour burden on the efficacy of PD‐1/PD‐L1 inhibitors plus chemotherapy in non‐small‐cell lung cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 2, p. 1451, doi. 10.1002/cam4.5035
- By:
- Publication type:
- Article
Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatments.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 9, p. 2455, doi. 10.1007/s00432-021-03784-3
- By:
- Publication type:
- Article
Prospective evaluation of the relationship between response and exposure of total and unbound erlotinib in non-small cell lung cancer patients.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Predicting the efficacy of first‐line immunotherapy by combining cancer cachexia and tumor burden in advanced non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 14, p. 2064, doi. 10.1111/1759-7714.14529
- By:
- Publication type:
- Article
Impact of losing adipose tissue on outcomes from PD‐1/PD‐L1 inhibitor monotherapy in non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1496, doi. 10.1111/1759-7714.14421
- By:
- Publication type:
- Article
Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 403, doi. 10.1007/s10637-021-01191-6
- By:
- Publication type:
- Article
Long-term survival data of patients with limited disease small cell lung cancer: a retrospective analysis.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 411, doi. 10.1007/s10637-021-01183-6
- By:
- Publication type:
- Article
Correction to: Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non‑small cell lung cancer.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Impact of weight loss on treatment with PD-1/PD-L1 inhibitors plus chemotherapy in advanced non-small-cell lung cancer.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 2, p. 1633, doi. 10.1007/s00520-021-06572-4
- By:
- Publication type:
- Article
Comparison of clinical features between immune-related sclerosing cholangitis and hepatitis.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1716, doi. 10.1007/s10637-021-01136-z
- By:
- Publication type:
- Article
Rechallenge with previously administered epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasis.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1732, doi. 10.1007/s10637-021-01140-3
- By:
- Publication type:
- Article
Long-term outcomes in extensive disease small cell lung cancer patients treated without immune checkpoint inhibitors.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1736, doi. 10.1093/jjco/hyab158
- By:
- Publication type:
- Article
Association between oligo-residual disease and patterns of failure during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Impact of angiogenesis inhibitor eligibility on the prognosis of patients with non‐small cell lung cancer harboring EGFR mutation.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 21, p. 7503, doi. 10.1002/cam4.4268
- By:
- Publication type:
- Article
Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer TRAP OLIGO study (WJOG11118L).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical impact of walking capacity on the risk of disability and hospitalizations among elderly patients with advanced lung cancer.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 7, p. 3961, doi. 10.1007/s00520-020-05953-5
- By:
- Publication type:
- Article
Correction to: Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Detection of programmed cell death-ligand 1 using 22C3 antibody in patients with unresectable stage III non-small cell lung cancer receiving chemoradiotherapy.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 4, p. 659, doi. 10.1007/s10147-020-01856-x
- By:
- Publication type:
- Article
Retrospective analysis of osimertinib re-challenge after osimertinib-induced interstitial lung disease in patients with EGFR-mutant non-small cell lung carcinoma.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 2, p. 571, doi. 10.1007/s10637-020-01005-1
- By:
- Publication type:
- Article
Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Real‐world efficacy of atezolizumab in non‐small cell lung cancer: A multicenter cohort study focused on performance status and retreatment after failure of anti‐PD‐1 antibody.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 5, p. 613, doi. 10.1111/1759-7714.13824
- By:
- Publication type:
- Article
Prospective evaluation and refinement of an S‐1 dosage formula based on renal function for clinical application.
- Published in:
- Cancer Science, 2021, v. 112, n. 2, p. 751, doi. 10.1111/cas.14758
- By:
- Publication type:
- Article
A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987647
- By:
- Publication type:
- Article
Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 1, p. 247, doi. 10.1002/cam4.3631
- By:
- Publication type:
- Article
Proposing synchronous oligometastatic non–small‐cell lung cancer based on progression after first‐line systemic therapy.
- Published in:
- Cancer Science, 2021, v. 112, n. 1, p. 359, doi. 10.1111/cas.14707
- By:
- Publication type:
- Article
A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987647
- By:
- Publication type:
- Article
Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1612, doi. 10.1007/s10637-020-00917-2
- By:
- Publication type:
- Article
Association Between Clinical Tumor Burden and Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L).
- Published in:
- 2020
- By:
- Publication type:
- journal article
PD-L1 expression and response to pembrolizumab in patients with EGFR-mutant non-small cell lung cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 5, p. 617, doi. 10.1093/jjco/hyaa033
- By:
- Publication type:
- Article
Evaluation of gefitinib systemic exposure in EGFR-mutated non-small cell lung cancer patients with gefitinib-induced severe hepatotoxicity.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Negative impact of malignant effusion on osimertinib treatment for non-small cell lung cancer harboring EGFR mutation.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 1, p. 194, doi. 10.1007/s10637-019-00808-1
- By:
- Publication type:
- Article
Acquired immunodeficiency associated with thymoma: a case report.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Leptomeningeal recurrence after long-term alectinib therapy for non-small cell lung cancer harboring an EML4-ALK fusion protein.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 1, p. 184, doi. 10.1007/s10637-018-0633-6
- By:
- Publication type:
- Article
Palliative cerebrospinal fluid shunting for leptomeningeal metastasis-related hydrocephalus in patients with lung adenocarcinoma: A single-center retrospective study.
- Published in:
- PLoS ONE, 2019, v. 14, n. 01, p. 1, doi. 10.1371/journal.pone.0210074
- By:
- Publication type:
- Article
Changes in programmed death ligand 1 expression in non-small cell lung cancer patients who received anticancer treatments.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 6, p. 1052, doi. 10.1007/s10147-018-1305-4
- By:
- Publication type:
- Article
Efficacy of second-line chemotherapy in poor-risk patients with refractory-relapsed small-cell lung cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 9, p. 822, doi. 10.1093/jjco/hyy107
- By:
- Publication type:
- Article
Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter.
- Published in:
- Cancer Science, 2018, v. 109, n. 8, p. 2539, doi. 10.1111/cas.13692
- By:
- Publication type:
- Article
Clinical Factors Predicting Detection of T790M Mutation in Rebiopsy for EGFR-Mutant Non-small-cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article